Abstract
Adjunctive therapy with adenosine has been shown to improve coronary flow in patients with acute coronary syndromes (ACS); it is unclear, however, whether adenosine can effectively reduce adverse clinical events. The aim of our study was to perform a meta-analysis of all randomized controlled trials (RCTs) investigating angiographic and clinical outcomes in ACS patients undergoing PCI or thrombolysis and receiving adjunctive adenosine therapy vs. placebo.
Lingua originale | English |
---|---|
pagine (da-a) | 1-7 |
Numero di pagine | 7 |
Rivista | ATHEROSCLEROSIS |
Volume | 222 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- acute coronary syndrome
- adenosine